ArticleFrontiers in oncology2022
Case Report: Submucosal gastroblastoma with a novel
Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 20 citations in OpenAlex.
- The indolent nature of gastroblastoma. Report of an illustrative case with 28 years of follow-up showing previously unreported immunohistochemical and molecular features.Virchows Archiv : an international journal of pathology · 2026Article
- Gastric mesenchymal tumor with PTCH1::GLI2 fusion: a distinct subset of GLI1/GLI2-altered tumors?Virchows Archiv : an international journal of pathology · 2026Article
- Gastroblastoma: a case report and literature review.Frontiers in oncology · 2026Article
- GLI1/2-altered mesenchymal tumors: a study of 8 cases expanding the clinicopathological and molecular spectrum including an upstream PTCH1-inactivating mutation.Virchows Archiv : an international journal of pathology · 2025Article
- Case Report: Gastric submucosal neoplasm withFrontiers in medicine · 2025Article
- Gastroblastoma - a case report and literature review.World journal of surgical oncology · 2024Review
- Gastric mesenchymal tumor with gastroblastoma-like features harboring PTCH1::GLI2 fusion.Virchows Archiv : an international journal of pathology · 2024Article
- Gastroblastoma with a novel ACTB::GLI1 gene fusion in a 19-year-old male.Virchows Archiv : an international journal of pathology · 2024Article
- Blastomas of the digestive system in adults: A review.World journal of gastrointestinal surgery · 2024Review
- Gastroblastoma: a case report and literature review.Frontiers in oncology · 2024Article
- MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.BMC cancer · 2023Article
- Gastroblastoma mimics the embryonic mesenchyme of the foregut: a case report.Diagnostic pathology · 2023Article
- Gastroblastoma Treated by Endoscopic Submucosal Excavation with a NovelCurrent oncology (Toronto, Ont.) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastroblastoma is a rare biphasic tumor of the stomach that generally presents in young patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.